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Abstract
Background: The acquisition of iron is important for the pathogenicity of bacteria and blood. Three different
culture environments (Fe stimulation, blood agar plate and normal plate) were used to stimulate Enterobacter
cloacae, and their respective pathogenicities were compared at the proteomic, mRNA and metabolomic levels.
Methods: 2D-DIGE combined with MALDI-TOF-MS/MS, RT-PCR and 1H NMR were used to analyze the differential
expression levels of proteins, mRNA and metabolites.
Results: A total of 109 proteins were identified by 2D-DIGE and mass spectrometry after pairwise comparison within
three culture environments, clustered into 3 classes and 183 functional categories, which were involved in 23
pathways. Based on the 2D-DIGE results, multiple proteins were selected for verification by mRNA expression.
These results confirmed that most of the proteins were regulated at the transcriptional level. Thirty-eight metabolites
were detected by NMR, which correlated with the differentially expressed proteins under different treatment conditions.
Conclusions: The results show that culture in a blood agar plate and a suitable concentration of iron promote the
pathogenicity of E. cloacae and that high iron concentrations may have adverse effects on growth and iron uptake and
utilization by E. cloacae.
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Background
Due to antibiotics that have been overly prescribed in
recent years, Enterobacter cloacae has emerged as an
important nosocomial pathogen in neonatal units, with
numerous outbreaks of infection being reported [1, 2]. E.
cloacae occur in water, sewage, soil, food, and as com-
mensal microflora in the intestinal tracts of humans and
animals [3]. Molecular biological studies of E. cloacae
have revealed six species, and some strains that have
been phenotypically identified as E. cloacae are oppor-
tunistic pathogens that have been implicated as the
causative agent of local and systemic infections in
humans [4]. They are important nosocomial pathogens
that are responsible for bacteremia, lower respiratory
tract, skin, soft tissue, urinary tract, intra-abdominal and
ophthalmic infections, endocarditis, septic arthritis and
osteomyelitis, especially the outbreaks of septicemia in
the neonatal intensive care unit [5, 6]. This bacterium
may be transmitted to neonates through intravenous
fluids, total parenteral nutrition solutions and medical
equipment. Common endogenous reservoirs of E. clo-
acae include the gastrointestinal tract of healthy adults
and the urinary and respiratory tracts of sick patients.
Sputum, secretions and pus, and urine are the most
studied specimens of human E. cloacae infection [7].
E. cloacae is isolated from the feces of 10–70 % of ne-
onates. Due to their relative lack of toxicity and ability
to cross the blood–brain barrier, these antimicrobial
agents have been increasingly used as first-line antibiotic
therapy in neonates. As a result, E. cloacae has become
super-bacteria in hospitals due to the presence of
* Correspondence: zhoujun1@nbu.edu.cn; suxiurong_public@163.com
School of Marine Science, Ningbo University, 818 Fenghua Road, Ningbo,
Zhejiang Province 315211, People’s Republic of China
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang et al. Proteome Science  (2016) 14:15 
DOI 10.1186/s12953-016-0104-y
extended-spectrum β-lactamases (ESBLs) [1]. Although
E. cloacae complex strains are among the most common
Enterobacter species causing nosocomial bloodstream
infections in the last decade, little is known regarding
their virulence-associated properties. Among the most
common risk factors for developing E. cloacae blood-
stream infections are prolonged hospitalization, the se-
verity of the illness, and exposure to invasive procedures
[4]. Additional predisposing factors are the usage of a
central venous catheter, prolonged antibiotic therapy,
parenteral nutrition and immunosuppressive therapy [8].
In our previous study, we obtained 98 strains of E.
cloacae from the Ningbo sewage outfall using rpoB
genotyping, multi-locus sequence analysis and compara-
tive genomic hybridization. Among the 98 strains of bac-
teria, the following virulence genes were identified: iron
regulatory protein 2 (irp2), ferrichrome-iron uptake recep-
tor (fhuA), superoxide dismutase B (sodB), and Shiga-
Like-Toxin A (sltA), with a detection rate of 35.71 % for
the fhuA+ irp2+ sodB+ genotype, 25.27 % for fhuA+ irp2+
sltA+, 13.19 % for irp2+, 12.09 % for fhuA+, 9.89 % for
fhuA+ irp2+, 8.79 % for sltA+ sodB+, and 8.79 % for fhuA+
irp2+ sodB+ sltA+ [9].
The ability of bacteria to acquire iron from the exter-
nal environment is known to have a strong relationship
with virulence [10, 11]. Iron is an essential element for
most bacteria; it is utilized as the reaction center for
redox enzymes and directly participates in redox reac-
tions by switching between the Fe2+ and Fe3+ states [12].
Among the Gram-positive pathogens, iron uptake in
Staphylococcus aureus has been investigated most exten-
sively [13]. In a study of Gram-negative bacteria isolated
from 120 neonate blood samples with clinical signs of
infection, E. cloacae accounted for the largest population
among the pathogenic bacteria [14]. The blood agar
plate is one of the most important methods for cultivat-
ing E. cloacae and other pathogenic bacteria to study
their pathogenicity [15]. Therefore, to study the patho-
genicity of E. cloacae isolated from sewage outfall, we set
out to compare the regulation of E. cloacae pathogen-
icity by blood and iron availability. We cultured E. clo-
acae in three different media, and then assessed
pathogenicity by 2D-DIGE, RT-PCR and nuclear mag-
netic resonance (NMR) at proteomic, mRNA and meta-
bolic levels.
Methods
Isolation, identification and culture of bacteria
E. cloacae was isolated from sewage outfalls along the
Ningbo coastline (Ningbo, China) and positively identi-
fied as Enterobacter cloacae ENHKU01 by sequencing
using universal primers (27 F: 5’-AGAGTTTGAT
CCTGGCTCAG-3’ and 1492R: 5’-GGTTACCTTGTT
ACGACTT-3’). E. cloacae was cultured on blood agar
plates in the first experimental group (hereafter referred
to as Y1) and in beef extract peptone medium (5 mg/mL
beef extract powder, 10 mg/mL peptone, 20 mg/mL agar,
all purchased from Microbial Reagent, Hangzhou,
China) in the control group (hereafter referred to as Y2).
In the second experimental group (hereafter referred to
as Y3), 0.1 mM FeCl3 (this concentration was selected
from a preliminary experiment with varying concentra-
tions of Fe3+, Additional file 1) was added to the same
medium for 12 h at 28 °C. All extractions and experi-
ments were performed in a cold room at 4 °C. E. cloacae
were washed twice with phosphate-buffered saline (PBS),
and the bacteria were collected after centrifugation
(6,000 rpm, 15 min, 4 °C).
Protein identification
Sample preparation and CyDye labeling
The bacteria were dissolved in 10 mL of lysis buffer
(8 mol/L urea, 2 mol/L thiourea, 4 % (w/v) CHAPS,
10 mg/mL of DTT, 2.5 mg/mL of Tris), and protein
was subsequently extracted by ultrasonic disruption
(200 W for 10 min) on ice. Centrifugation (12,000 rpm,
30 min, 4 °C) was used to pellet the cell debris, and the
supernatant was mixed with 5 times its volume of acetone
(containing 10 % TCA). The proteins were precipitated
for 6 h at −20 °C, and the supernatant discarded after cen-
trifugation (12,000 rpm, 30 min, 4 °C). The pellet was re-
suspended in acetone and centrifuged (12,000 rpm,
30 min, 4 °C), and the precipitate was dried in a draft cup-
board. The protein pellet was resuspended in rehydration
buffer (8 mol/L urea, 2 mol/L thiourea, 40 mg/mL
CHAPS, 10 mg/mL of DTT). Finally, the protein concen-
tration was determined using a 2-D Quant Kit (Amersham
Biosciences, USA) with BCA (2 mg/mL) as the standard.
The optimal concentration of the protein sample was be-
tween 5 and 10 mg/mL.
For each sample, 30 μg of protein was mixed with
1.0 μl of diluted CyDye (1:5 diluted with dimethyl form-
amide from a 1 nmol/μl stock) and maintained in the
dark on ice for 30 min. Samples from each pair were la-
beled with Cy3 and Cy5, respectively, while the same
amount of the pooled standard containing equal quan-
tities of all samples was labeled with Cy2 (Table 1). The
three labelled and quenched samples were combined,
Table 1 DIGE experimental design for sample protein labeling
from different treatments and internal standard
Gel No. Cy2 Cy3 Cy5
Gel 1 Y1 + Y2 + Y3 Y1 Y2
Gel 2 Y1 + Y2 + Y3 Y2 Y1
Gel 3 Y1 + Y2 + Y3 Y3 Y2
Gel 4 Y1 + Y2 + Y3 Y1 Y3
Gel 5 Y1 + Y2 + Y3 Y3 -
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and a total of 150 μg of protein was mixed and added to
the rehydration buffer and 0.5 % Immobilized pH gradi-
ent (IPG) buffer (GE Healthcare, USA) to a final volume
of 460 μL.
Two-dimensional gel electrophoresis
After loading the labeled samples onto 22-cm pH 4–7
linear IPG strips (GE Healthcare, USA), iso-electric fo-
cusing (IEF) was performed as follows: 12 h of rehydra-
tion at 20 °C, followed by 300 V for 45 min, 700 V for
45 min, 1,500 V for 1.5 h, 9,000 V for 27,000 VHr, and
9,000 V for 36,000 VHr. After IEF, the IPG strips were
equilibrated for sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) in 5 mL equilibration
buffer (0.05 M Tris–HCl (pH 8.8), 6 M urea, 30 % (v/v)
glycerol, 2 % (w/v) SDS and a trace amount of bromo-
phenol blue) containing 1 % DTT for 15 min, followed
by a second equilibration step of 15 min with the same
buffer containing 2.5 % (w/v) iodoacetamide. The equili-
brated strips were loaded on the top of 12 % SDS-
polyacrylamide gels and sealed with 0.5 % (w/v) agarose.
The SDS-PAGE step was performed at 15 °C in an Ettan
Dalt Twelve (Amersham Biosciences, USA) electrophor-
esis system at 2 W/gel for 45 min, followed by 17 W/gel
for approximately 4.5 h (until the bromophenol blue
reached the bottom of the gel).
Image acquisition and analysis
The CyDye-labelled gels were visualized using a
TyphoonTM 9400 imager (GE Healthcare, USA) with the
appropriate excitation and emission wavelength filters for
each dye, according to the manufacturer’s recommenda-
tions. All images were processed using Imagemaster 7.0
and then analyzed with DeCyder software (GE Healthcare,
USA). The intra-gel analysis was performed using the
DeCyder Difference In-gel Analysis system, and inter-gel
matching was performed using the DeCyder Biological
Variance Analysis, Statistical analyses were conducted for
each sample. The spot volume ratios that showed a statis-
tically significant (abundance variation of at least 1.5-fold,
p < 0.05) difference were processed for further analysis.
Protein digestion and mass spectrometric analysis
Selected protein spots were excised from the preparative
gels. Each small gel plug was destained with 100 μL of
ACN in 50 mM ammonium hydrogen carbonate for ap-
proximately 1 h at room temperature, and this step was
repeated until the gel was colorless. After evaporation of
the solvent by vacuum centrifugation, each gel plug was
rehydrated with 20 μL of 0.01 mg/mL sequencing-grade
modified trypsin (Promega, Madison, WI, USA), and the
mixture was agitated overnight at 37 °C. The superna-
tants were collected, and the gel pieces were rinsed once
with 5 % TFA in 50 % ACN and then twice with 2.5 %
TFA in 50 % ACN. The supernatants were then com-
bined and lyophilized. The lyophilized peptides were dis-
solved in 5 mg/mL CHCA (Sigma, USA) in 50 % ACN
and 0.1 % TFA. All MS/MS experiments were performed
on an Autoflex speed™ MALDI-TOF-MS/MS analyzer
(Bruker Daltonics, Germany). The detection conditions
were as follows: UV wavelength, 355 nm; recurrence
rate, 200 Hz; accelerating voltage, 20,000 V; optimal
mass resolution, 1,500 Da; mass of scanning range, 700–
3,200 Da. The MS data were processed by flex Analysis
(Bruker Daltonics, Germany) to produce a PKL file and
analyzed with the NCBI protein sequence database using
BioTools (Bruker Daltonics, Germany) via the Mascot
search engine.
Biological analysis
Gene ontology (GO) annotations were performed for the
identified sequences by MS/MS using BLASTx in the
NCBI database. Blast2GO software was then used to an-
notate the sequence hits by BLASTx (sequences with
scores of E > 1e − 05 were discarded). The GO hierarchical
terms of homologous genes from the Interpro protein da-
tabases were extracted to assign putative functions to the
unique sequences. In addition, unique sequences with
homology to enzymes involved in metabolic pathways
were mapped in accordance with the Kyoto Encyclopedia
of Genes and Genomes (KEGG) database. Enzyme com-
mission (EC) numbers were acquired for unique se-
quences by WUBLASTx searching of the KEGG database.
The EC numbers were then used to putatively map unique
sequences to specific biochemical pathways.
Confirmation of the mRNA level by RT-PCR
RNA extraction and cDNA synthesis
Total RNA was extracted from frozen cell pellets using
the RNeasy mini RNA extraction kit (Qiagen, Germany)
according to the manufacturer’s instructions. Contamin-
ating genomic (gDNA) was removed using on-column
DNaseI digestion performed using the DNaseI digestion
kit (Qiagen, Germany). Elution of total RNA was per-
formed using 50 μl of DNase/RNase-free H2O, and
quantified with a NanoDrop 2000 UV–vis spectropho-
tometer (Thermo Scientific, USA).
Total RNA (4 μg) was used as a template for reverse
transcriptase reactions, which were carried out in paral-
lel with M-MuLV Reverse Transcriptase (Sangon Bio-
tech, Shanghai, China), following the manufacturer’s
instructions. Briefly, total RNA was mixed with 10 μM
of random hexanucleotide primers, incubated for 5 min
at 70 °C, and kept on ice for 2 min to allow
hybridization. Then, RT reaction Mix (buffer 5X,
10 mM each dNTP, RNase inhibitor (20 U/μL)) and re-
verse transcriptase were added according to the manu-
facturer’s instructions. After 60 min of incubation at
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42 °C, the RT enzyme was heat-inactivated at 70 °C. In
each case, the total reaction volume was 20 μL.
RT-PCR
Target genes associated with pathogenicity were selected
based on the results of the 2D-DIGE analysis. The
encoded protein sequence was matched using the NCBI
database. Primers used for RT-PCR were designed using
Primer3 software and are listed in Additional file 2. The
amplification efficiency of the primers for the target
genes and the reference gene were validated using the
same program.
RT-PCR assays were performed in strip tubes (Qiagen,
Germany) in a Rotor-Gene 6000 Real-Time PCR machine
(Corbett, Australia) following the protocol provided with
SYBR® Premix Ex TaqTM II (TaKaRa, JAPAN). Each reac-
tion consisted of four biological replicates and was con-
ducted in 2 μL of cDNA and 18 μL reaction mixture
containing 10 μL SYBR® Premix Ex TaqTM II (2X), 0.8 μL
PCR forward primer (10 μM), 0.8 μL PCR reverse primer
(10 μM), 2 μL template, and 6.4 μL ddH2O. Each amplifi-
cation consisted of a denaturation step of 10 s at 95 °C,
followed by 40 cycles of 15 s denaturation at 94 °C, 10 s
annealing at 55 °C and elongation for 10 s at 72 °C,
and then a single fluorescence measurement. Diethyl
pyrocarbonate (DEPC)-treated water was used as the
negative control.
Detection of metabolites
Metabolites were extracted from the bacterial pellets by
the addition of 10 ml methanol:water = 2:1, followed by
cell lysis by ultrasonic disruption at 200 W for 15 min
on ice and centrifugation (12,000 rpm, 10 min, 4 °C).
The supernatant was collected, and the methanol was
removed with a swab in the solid phase extraction cart-
ridge. The supernatant was then stored at −80 °C, and
the metabolites were freeze-dried. The samples were
then transferred onto a pre-washed ultrafiltration mem-
brane and centrifuged (6,000 rpm, 30 min, 4 °C) twice. Fil-
trates were collected and mixed with ACDSS (Anachro
Certified DSS Standard Solution), vortexed (10 s) and cen-
trifuged (13,000 rpm, 2 min, 4 °C).
The 1H NMR measurements were performed at
298 K on a Bruker Avance III 600 MHz spectrometer
equipped with an inverse detection cryogenic probe
(Bruker Biospin, Germany), which was operated at
600.13 MHz for a 1H resonance frequency. A noesypr1d/
noesygppr1d pulse sequence was used to determine the
bacterial metabolite profiles. One hundred twenty-eight
transitions were collected as 32,768 data points for each
spectrum. The 1H NMR signal was imported into the
Chenomx NMR suite version 7.6 (Chenomx, Canada),
and the data were automatically Fourier-transformed,
phase-adjusted and baseline-adjusted. Metabolites from E.
cloacae were quantified using the concentration and peak
area of DSS-d6 (2,2-dimethyl-2-silapentane-5-sulfonate-
d6 sodium salt) as the standard.
Results
Differential expression of E. cloacae proteins
2D-DIGE was applied to analyze the changes in the
proteome of E. cloacae under the different culture con-
ditions. The gel images from the 2D-DIGE separation of
E. cloacae are presented in Fig. 1. An average of 1,700
spots were detected in all five 2D-DIGE gels; 720 spots
were reproducibly matched to all samples (triplicate
runs), and the protein regulatory conditions and the suc-
cess rate of detection by MS/MS are listed in Table 2.
Among the three samples from the three culture condi-
tions, changes greater than 1.5-fold and p-values < 0.05
were considered significant changes in protein abun-
dance. The regulated proteins were selected for identifi-
cation by MS/MS (Fig. 2), and Additional file 3 shows
the MS/MS-identified proteins from E. cloacae cultured
under three different conditions. A total of 109 types of
protein were successfully identified by MS/MS, which
identified 3 or more unique peptides with a confidence of
95 % at the protein level and 99 % at the peptide level.
GO annotation
To understand the biological functions of the differentially
expressed proteins under the three treatment conditions,
GO annotation was performed. GO representation of the
E. cloacae clusters was categorized according to the bio-
logical process, cellular component and molecular func-
tion (Fig. 3). Each identified protein was classified
according to its GO functional annotation. These differen-
tially expressed proteins were mainly localized in the cel-
lular outer membrane, cytoplasm, and plasma membrane
and to participate in ATP binding, protein transport and
transporter activity.
According to the KEGG metabolic pathway maps of E.
cloacae, a total of 23 pathways were clustered into three
groups together with the differentially expressed proteins
(Fig. 4). Among them, the ABC transporters, citric acid
cycle (TCA cycle), glycerophospholipid metabolism, pur-
ine metabolism and pyrimidine metabolism were the
pathways that were most influenced by the differentially
expressed proteins.
RT-PCR analysis of differentially expressed proteins
Twenty-seven genes corresponding to the protein spots
that were highly differentially expressed, or related to
pathogenicity, were selected for RT-PCR analysis to val-
idate their transcript levels. The relationship between
the level of protein and mRNA is displayed in Additional
file 4. The RT-PCR results were consistent with those of
the DIGE studies and suggested that some proteins that
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were identified as differentially abundant were regulated
at the transcriptional level (positive correlation), such as
the expression of F0F1 ATP synthase subunit beta (B20),
whereas others were not (negative correlation), including
the type VI secretion system protein ImpC (A11). Fur-
thermore, some proteins showed no significant correl-
ation between the expression of protein and the gene,
such as outer membrane channel protein (A15).
1H NMR spectroscopic analysis of metabolites of E.
cloacae
The 1H NMR spectra revealed several metabolites that
were modified in E. cloacae stimulated by the blood agar
plate and Fe (Figs. 5 and 6). A total of 38 individual metab-
olites were detected in the three treatment groups. Among
the 38 types of metabolites, 35 were detected in all treat-
ment groups, thymine and phenylacetate were only de-
tected in normal culture, and NAD+ was not detected in
the control group. Additionally, O-phosphocholine was not
detected in the blood agar plate culture.
Three treatments effects on E. cloacae metabolites were
emphasized during PCA and PLS-DA (Fig. 7). The PCA
(principal component analysis) and PLS-DA (partial least
squares discriminant analysis) showed that fumarate, acet-
ate, ethanolamine, 2-aminoadipate, glutamate, 2-alanine,
glycine, alanine and succinate made an important contri-
bution to distinguishing among the three samples.
Comparison of pathways affected by differentially
expressed proteins by the differentially expressed
metabolites
The metabolome adds an additional level of information
in biological systems that reflects phenotypic and func-
tional variation. Metabolites identified by 1H NMR were
used to verify the pathways affected by the differentially
expressed proteins. First, we classified the pathways into
those that were dysregulated in only one treatment
Fig. 1 Proteomic comparison of E. cloacae under three different
culture conditions using 2D-DIGE. Protein samples (150 μg each)
from total E. cloacae lysates were labeled with Cy-dyes and separated
using 22-cm, pH 4–7 linear IPG strips. Note: A-gel1, B-gel2, C-gel3,
D-gel4, E-gel5
Table 2 The condition of the different expression of proteins










Y1:Y2 35a (30)b 67 (35) - 63.73 %
Y1:Y3 64 (45) - 91 (76) 78.06 %
Y2:Y3 - 50 (28) 58 (49) 71.30 %
aThe number of upregulated proteins. bThe number of protein which detected
successfully by MS/MS
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Fig. 2 Proteins exhibiting significant changes were selected for MS/MS identification. A and B denote the upregulated proteins in Y1 and Y2 and
in Y1 compared with Y2, respectively. C and D denote the upregulated proteins in Y1 and Y3 and in Y1 compared with Y3, respectively. E and F
denote the up-regulated proteins in Y2 and Y3 and in Y2 compared with Y3, respectively
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Fig. 3 GO categorization of differentially expressed proteins in E. cloacae cultured under three different conditions. The proteins were classified as
follows: cellular component, molecular function, and biological processes, according to the GO terms. The color of the square is related to the
number of times each function was clustered by proteins; a higher frequency is represented by richer shades of each respective color
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group, and then we selected the metabolites that dis-
played statistically significant changes in abundance (at
least 1.5-fold, p < 0.05) (Tables 3, 4, 5). Most pathways
were verified by the different metabolites, such as in
Y1:Y2, and ABC transporters were regulated by proteins
that were upregulated in Y2. Eleven metabolites were as-
sociated with this pathway, in which 9 compounds (ala-
nine, betaine, glycine, isoleucine, leucine, methionine,
phenylalanine, valine, threonine) had a high abundance
in the Y2 treatment group and 2 compounds (glutamate,
2-alanine) were highly expressed in the Y1 treatment
group.
Discussion
Proteins involved in iron uptake and utilization
Transport proteins play an important role in pathogen-
icity. This class includes toxins, trans-envelope protein
secretion systems, outer membrane protein secretion
systems and outer membrane iron-siderophore receptors
that function with cytoplasmic membrane ABC-type
iron uptake transporters [16]. In our limited research,
we were interested in investigating transport proteins re-
lated to iron absorption and transportation, and in cor-
relating them with pathogenicity.
In the comparison of Y1 and Y2, the ferrichrome outer
membrane transporter (A02, A05), L-serine ammonia-
lyase (A14), and hypothetical protein EcWSU1_01016
(A08) (GO cluster analysis associated this protein with
metal ion binding (GO:0046872)) were upregulated in E.
cloacae cultured on a blood agar plate. The sheep blood
used in this plate provided the iron ions required by E.
cloacae, improving its pathogenicity.
In Y1 compared with Y3, the upregulated proteins link-
ing iron absorption and transportation in Y2 were ferric
aerobactin receptor (C08), ferrichrome outer membrane
transporter (C10, C12, C15), phosphoenolpyruvate-
protein phosphotransferase (C19), hypothetical protein
EcWSU1_01016 (C21) and LamB type porin (C32). The
expression of these 6 proteins was up-regulated more
than 5-fold in Y1 compared with Y3. In contrast, the
levels of 2’,3’-cyclic-nucleotide 2’-phosphodiesterase/3’-
nucleotidase (D06), maltose ABC transporter periplas-
mic protein (D30, D40, D41, D68, D69, D77),
phenylacetate-CoA oxygenase, NAD(P)H oxidoreduc-
tase component (D31), 6-phosphofructokinase (D44),
methionine aminopeptidase (D53), phenylacetic acid
degradation protein paaC (D60), osmolarity response
regulator (D62), bifunctional acetaldehyde-CoA/alco-
hol dehydrogenase (D63), succinate dehydrogenase
iron-sulfur subunit (D66) and NADH-quinone oxido-
reductase subunit E (D79) were up-regulated more
than 5-fold in Y3 compared with Y2. The most up-
regulated protein was maltose ABC transporter peri-
plasmic protein (D30), with a more than 59-fold in-
crease in expression. The DIGE results suggested that
E. cloacae expresses more proteins to absorb and
transport iron under iron-rich culture conditions. The
growth curve of E. cloacae under different culture
conditions and varying concentrations of Fe3+ re-
vealed that high concentrations of Fe3+ had a certain
inhibitory effect on growth. Although we selected a
Fe3+ concentration that could promote the growth of
E. cloacae, we hypothesize that it is difficult for the
bacteria to take up and utilize iron from the blood
agar plate culture. However, a continuous increase in
the concentration of Fe3+ may inhibit growth as well
as iron uptake and utilization (Additional file 1).
This speculation was confirmed in Y2 compared with
Y3 group. We found that some of the previously men-
tioned proteins related to iron uptake and utilization were
upregulated in the common Y2 culture, such as ferric
aerobactin receptor (E05), ferrichrome outer membrane
transporter (E07), and LamB type porin (E22), among
others. In comparisons of the iron concentration, a greater
content was detected in Y3 compared with Y1. These find-
ings further suggest that the concentration of iron is im-
portant for the growth and pathogenicity of the bacteria.
The identification of the ferric uptake regulator (Fur)
family was quite interesting. Fur plays a crucial role in
bacterial metabolism, and iron deficiency is the most
common nutritional stress during the process of cell
Fig. 4 Details of the pathways that cluster with the differentially
expressed proteins in the three groups. The color of the square is
related to the number of regulated proteins clustered in the
pathways; richer shades of each respective color indicate a
higher number
Zhang et al. Proteome Science  (2016) 14:15 Page 8 of 14
survival [17]. In most prokaryotic organisms, Fur con-
trols iron metabolism and plays a role in the regulation
of defenses against oxidative stress. It regulates the ex-
pression of iron-binding proteins, which depend on the
concentration of iron in the cell [18].
Glycerophospholipid metabolism and ATP-binding
cassette (ABC) transporters
After comparing all of the identified pathways, we ob-
served a relationship between glycerophospholipid me-
tabolism and ATP-binding cassette (ABC) transporters
in Y1 compared with Y3. Although higher throughput
protein analysis technology such as iTRAQ [19] and
higher frequency NMR [20] were not used in our limited
research, we still identified the relationship between the
proteins and metabolites.
First, during glycerophospholipid metabolism, we lo-
cated 2 dysregulated proteins using DIGE: glyceropho-
sphodiester phosphodiesterase (EC:3.1.4.46, F32) and
phospholipase A (EC:3.1.1.4, EC:3.1.1.32, E42). Part A of
Fig. 8 shows that phospholipase A can catalyze two
biosynthetic processes that utilize phosphatidylcholine to
synthesize 1-acyl-sn-glycero-3-phosphocholine and 2-
acyl-sn-glycero-3-phosphocholine. Subsequently, lyso-
phospholipase synthesizes sn-glycero-3-phosphocholine.
In Y1, we speculate that sn-glycero-3-phosphocholine
accumulated because of the increased expression level of
phospholipase A and the down-regulation of glycero-
phosphodiester phosphodiesterase. The metabolomic
results corroborated this hypothesis because the con-
centration of sn-glycero-3-phosphocholine in Y1 was
up-regulated more than 6-fold compared with Y3.
In part B of the glycerophospholipid metabolism ana-
lysis (Fig. 8), although glycerophosphodiester phospho-
diesterase was highly expressed, we did not detect a
difference in sn-glycerol 3-phosphate between the Y1
and Y3 treatment groups. After searching the path-
ways associated with sn-glycerol 3-phosphate, we found
that sn-glycerol 3-phosphate also belongs to the ABC
transporter family. After sequencing the genome of
Edwardsiella tarda EIB202, Wang et al. identified and lo-
calized a large number of ABC system components. The
Fig. 5 Typical 600 MHz 1H NMR spectra of E. cloacae extract. 1: isoleucine; 2: ethanol; 3: leucine; 4: valine; 5: threonine; 6: lactate; 7: alanine; 8:
thymine; 9: acetate; 10: glutamate; 11: methionine; 12: 2-aminoadipate; 13: pyruvate; 14: succinate; 15: 2-alanine; 16: aspartate; 17: lysine;
18: ethanolamine; 19: choline; 20: O-phosphocholine; 21: sn-glycero-3-phosphocholine; 22: betaine; 23: 3-methylxanthine; 24: phenylacetate;
25: glycine; 26: inosine; 27: adenosine; 28: uracil; 29: cytosine; 30: fumarate; 31: tyrosine; 32: phenylalanine; 33: nicotinate; 34: uridine; 35:
hypoxanthine; 36: adenine; 37: formate; 38: 4-aminobutyrate
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ETAE_0613 and ETAE_0907 components of the ABC sys-
tem are potential virulence genes, which may provide
insight into the relationship between the output of viru-
lence factors and antibiotics and the acquisition of sn-
glycerol 3-phosphate [21].
The ATP-binding cassette (ABC) transporters form
one of the largest known protein families and are wide-
spread in bacteria, archaea, and eukaryotes. They couple
ATP hydrolysis to the active transport of a wide variety
of substrates such as ions, sugars, lipids, sterols,
peptides, proteins, and drugs. ABC transporters are ded-
icated to the export of virulence factors under appropri-
ate conditions such as our iron-rich culture condition.
An example is provided by iron ABC uptake systems,
which have long been recognized as important effectors
of virulence [22]. Because iron exists primarily in the
Fig. 7 PCA (a) and PLS-DA (b) score plot illustrating the variance between 38 metabolites under the three treatment conditions applied to E.
cloacae. 1: 2-aminoadipate, 2: 3-methylxanthine, 3: 4-aminobutyrate, 4: acetate, 5: adenine, 6: adenosine, 7: alanine, 8: aspartate, 9: betaine,
9: choline, 10: cytosine, 11: ethanolamine,12: formate, 13: fumarate, 14: glutamate, 15: glycine, 16: hypoxanthine, 17: inosine, 18: isoleucine, 19: lactate,
20: leucine, 21: lysine, 22: methanol, 23: methionine, 24: NAD+, 25: nicotinate, 26: O-phosphocholine, 27: phenylacetate, 28: phenylalanine, 29: pyruvate,
30: succinate, 31: threonine, 32: thymine, 33: tyrosine, 34: uracil, 35: uridine, 36: valine, 37: sn-glycero-3-phosphocholine, 38: 2-alanine
Fig. 6 Venn diagram and histogram of the quantified levels of metabolites detected in E. cloacae under the three different treatment conditions
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insoluble Fe3+ form under aerobic conditions, biologic-
ally available iron in the body is found chelated by high-
affinity iron-binding proteins (BPs) (e.g., transferrins,
lactoferrins, and ferritins) or as a component of erythro-
cytes (such as heme, hemoglobin, or hemopexin) [23].
Pathogens are able to scavenge iron from these
sources by secreting high affinity iron-complexing
molecules called siderophores and reabsorbing them
as iron-siderophore complexes [24]. For example,
lactoferrin-binding protein B (LbpB) is a bi-lobed
membrane-bound lipoprotein that is part of the lacto-
ferrin receptor complex in a variety of Gram-negative
pathogens [25]. Our DIGE results revealed the loca-
tion of the iron complex transport system based on
the differential expression of the iron-hydroxamate
transporter ATP-binding subunit (EC: 3.6.3.34, F41)
(using DIGE, F41 were identified as an osmolarity re-
sponse regulator by MS/MS, after transformation in
the E. cloacae subsp. cloacae ENHKU01 by BLAST,
the spot was confirmed to be iron-hydroxamate trans-
porter ATP-binding subunit, with 95 % confidence).
After comparing the expression of this protein among
the three treatment groups, the abundance was
ranked as Y3 > Y1 > Y2. This result indicated that Fe
stimulation of E. cloacae was greater in the medium
with Fe supplementation than in the blood agar plate.
Bacterial secretion system
The host interactions of pathogenic bacteria are usually
mediated via protein secretion mechanisms. Gram-
negative pathogenic bacteria will transport protein to
the extracellular environment or to the host cell
through devices called secretion systems. To date, a
least six different types of secretion systems have been
discovered in Gram-negative pathogenic bacteria (I-VI
secretion system). These systems can stimulate and
interfere with the processes of host cells by secreting or
releasing and injecting extracellular proteins or effec-
tors [26]. Using DIGE, we located two types of secre-
tion systems, type I and VI, based on the differential
expression of the outer membrane channel protein
Table 3 Validation of pathways affected by in difference
expression protein by the different metabolic detected by 1H






Y1 upregulated Two-component system 1a 2b
Y2 upregulated ABC transporters 2c 9d
Glycine, serine and threonine
metabolism
- 4g
Methane metabolism - 5h
Pentose phosphate pathway - 1l
Phenylalanine metabolism - 4k
Pyrimidine metabolism 1e 5f
Y1 and Y2
Co-regulated
Bacterial chemotaxis - -
Bacterial secretion system - -
Glycolysis / Gluconeogenesis 1i 2j
aGlutamate. bSuccinate, Fumarate. cGlutamate, 2-Alanine. dAlanine, Betaine,
Glycine, Isoleucine, Leucine, Methionine, Phenylalanine, Valine, Threonine.
e2-Alanine. fAlanine, Thymine, Uracil, Cytosine, Uridine. gBetaine, Glycine,
Pyruvate, Threonine. hGlycine, Acetate, Formate, Pyruvate, Methanol. iLactate.
jAcetate, Pyruvate. kPhenylalanine, Succinate, Fumarate, Pyruvate. lPyruvate
Table 4 Verify pathways affected by in difference expression







Y3 upregulated Bacterial secretion system - -
Butanoate metabolism - 3a
Nitrogen metabolism - 1b
Bacterial chemotaxis - 1c
Phenylalanine metabolism - 4d




Methane metabolism - 5f
Oxidative phosphorylation - 3g
Pentose phosphate pathway - 1h
Glycine, serine and threonine
metabolism
- 6i
ABC transporters - 13j
Y1 and Y3
Co-regulated
Pyruvate metabolism - 5k
Citrate cycle - 3l
Glutathione metabolism - 1m
Phosphotransferase system - 1n









Pyrimidine metabolism - 4t
Purine metabolism - 5u
aSuccinate, Fumarate, Pyruvate. bFormate. cAspartate. dPhenylalanine,
Succinate, Fumarate, Pyruvate. eFumarate, Pyruvate. fGlycine, Acetate, Formate,
Pyruvate, Methanol. gSuccinate, NAD+, Fumarate. hPyruvate. iAspartate,
Betaine, Choline, Glycine, Pyruvate, Threonine. jAlanine, Aspartate, Betaine,
Glycine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Choline,
Succinate, Valine, Threonine. kSuccinate, Acetate, Formate, Fumarate, Pyruvate.
lSuccinate, Fumarate, Pyruvate. mGlycine. nPyruvate. oAspartate, NAD+,
Fumarate, Pyruvate, Nicotinate. pAspartate, Succinate, Fumarate. qAcetate,
Pyruvate. rsn-Glycero-3-phosphocholine.sEthanolamine, Choline. tAlanine, Uracil,
Cytosine, Uridine. uGlycine, Adenine, Adenosine, Hypoxanthine, Inosine
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(TolC), type VI secretion system secreted protein Hcp
(hemolysin co-regulated protein) and type VI secretion
system protein ImpC.
The type I secretion systems (T1SS) are responsible
for the release of a variety of extracellular proteins and
extracellular enzymes [27]. TolC, which we identified by
DIGE, is associated with multiple drug resistance in bac-
teria. The expression of TolC in the three treatment
groups was as follows: Y1 > Y2 > Y3. Although the ma-
jority of research investigating type I secretion systems
has focused on multiple drug resistance, it can be specu-
lated from the results of our study that the protein also
has an association with pathogenicity and participates in
responses to differences in iron stimulation.
In contrast, type VI secretion systems (T6SS) have a
clear and strong correlation to pathogenicity, and
nearly all confirmed functional T6SS are poisonous to
macrophages [28]. Hcp can cross the T6SS transport
channel to enter the plasma and interact with the
host through the help of lipoprotein [29]. Due to pro-
tein modifications or degradation, as mentioned previ-
ously, in the group of Y1 compared with Y2, similar
Hcp levels were observed. In contrast, in Y1 com-
pared with Y3, the expression of Hcp in Y3 was al-
most 10-fold higher than that in Y1. Similarly, the
type VI secretion system protein ImpC was approxi-
mately 2-fold higher in Y3 than in Y2. These findings
Table 5 Verify pathways affected by in difference expression







Y3 upregulated Bacterial secretion system - -
Glycolysis/Gluconeogenesis - -
Pentose phosphate pathway - -
Pyruvate metabolism - 1a
Citrate cycle - 1b
ABC transporters 1c 6d
Y2 and Y3
Co-regulated
Phenylalanine metabolism 1e -
Glycine, serine and threonine
metabolism
1f 3g
Glutathione metabolism - 2h




Pyrimidine metabolism - -
Purine metabolism - -
aFumarate. bFumarate. cBetaine. dAspartate, Glutamate, Glycine, Leucine,
Lysine, Choline. eFumarate. fBetaine. gAspartate, Glycine, Choline.
hGlutamate, Glycine
Fig. 8 Glycerophospholipid metabolism in Y1 compared with Y3. The enzymes shown in purple were upregulated in Y1, and those shown in
yellow were upregulated in Y3
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indicated that the secretion of Hcp was regulated by
iron, which supports the research of Wang et al., who
found that iron was one of the regulators of the T6SS
component evpP in Edwardsiella tarda [30].
Two-component system
Two-component signal transduction systems enable bac-
teria to sense, respond, and adapt to changes in their en-
vironment or in their intracellular environment. In this
experiment, differences in the two-component system
were observed between Y1 and Y2 and between Y1 and
Y3, but not between Y2 and Y3. The differentially
expressed proteins were involved in resistance to the os-
motic upshift (K+). This result was consistent with our
experimental design, and the major difference between
the Y2 and Y3 culture conditions was the presence of
iron; however, in Y1, the blood agar plate culture condi-
tion was the main difference compared with Y2 and Y3,
in which the sheep blood fiber is enriched with a variety
of elements, including K+. Bacteria are sensitive to
changes in the external environment, and consequently
they undergo a series of mechanisms to adapt and pro-
tect themselves. Specifically, they must protect them-
selves against the immune response of the host during
infection. In the blood agar plate condition, K+ poten-
tially caused a change in osmotic pressure, stressing the
cells and potentially leading to cell lysis and death. As a
result, the two-component system probably helped the
bacteria resist the change in osmotic pressure and pro-
tected them by regulating the expression of outer mem-
brane proteins. Although the system has mainly been
reported in terms of bacterial responses to climate
change, the present study also shows that the system
plays a role in pathogenicity. The system can adjust the
various metabolic processes of bacteria, the bacterial cell
cycle, the exchange of signals between bacteria and the
expression of virulence factors [31].
Conclusion
The regulation of environmental factors leads to both
physiological and biochemical changes in bacteria. As a
result, the pathogenicity of the bacteria also changes in
response to environmental stimuli. The results of this
study showed that the blood agar plate and a suitable
concentration of iron ions enhanced the pathogenicity of
E. cloacae and that very high concentrations of iron may
have had an adverse effects on growth and on iron up-
take and utilization by this bacteria. It is difficult to
make an absolute comparison of the stimulatory effect
of blood versus iron on pathogenicity. The pathogenicity
of E. cloacae is affected by their living conditions and
the condition of the bacteria.
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